Page 8 - Stacey Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time St. Jude influenza research earns renewed NIH funding Richard Webby, Ph.D., of the St. Jude Department of Infectious Diseases, is principal investigator for the CEIRR program at St. Jude and director of the World Health Organization Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds. The National Institute of Allergy and Infectious Diseases, (NIAID), an affiliate of the National Institutes of Health, is providing an estimated $24 million to support five Centers of Excellence for Influenza Research and Response (CEIRR), including at St. Jude Children’...

HIN The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks. The program, called the Centers of Excellence for Influenza Research and Response (CEIRR), is expected to be supported for seven years by NIAID contracts to five institutions. Funding for the first year of the contracts will total approximately $24 million. CEIRR will replace the Ce...

 E-Mail IMAGE: Colorized transmission electron micrograph of swine influenza virus particles (green) attached to and budding from the surface of a cell (purple). view more  Credit: NIAID WHAT: The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks. The program, called the Centers of Excellence for Influenza Research and Response (C...

The Pandemic Broke the Flu Katherine J. Wu Editor’s Note: The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection here. In November, as fall was fading, Matt Binnicker began to hunker down for a hard winter. The coronavirus had already infected an estimated 13 million people nationwide, and his team at the Mayo Clinic in Rochester, Minnesota, was now peering over the precipice of flu season, when every coughing, feverish patient would need not one diagnostic test, but two. Determined to stay one step ahead, Binnicker’s lab ha...

COVID-19 vaccines could end the pandemic by eliminating severe cases Kate Baggaley © Provided by Popular Science As the vaccine distribution ramps up over the next few months, there should be another boon: a huge drop in the occurrence of severe COVID-19. The Biden administration announced this week that it will purchase an additional 200 million doses of the COVID-19 vaccines from Pfizer and Moderna, which means the United States will have enough vaccine doses to immunize 300 million people (nearly all of the country’s 328 million residents) by the end of the summer. In ...